Carsgen Therapeutics Is A Biopharmaceutical Company Operating In China And The United Statesit Focuses On Developing Innovative Chimeric Antigen Receptor Tcar Tcell Therapies Aimed At Addressing Unmet Clinical Needs In Treating Hematologic Malignancies And Solid Tumorsthe Company Is Dedicated To Becoming A Global Leader In Providing Differentiated Cell Therapies For Cancer Patientswith The Goal Of Making Cancer Curable The Company Has Established A Comprehensive Research And Development Platform For Car T Cell Therapieswhich Includes Target Discoveryinnovative Developmentclinical Trialsand Commercial Scale Productioncarsgen Is Also Building Manufacturing Facilities In Durhamnorth Carolinawhich Will Support The Production Of Fda Approved Cell Therapieswith A Strong Product Pipeline And A Commitment To Improving Treatment Safety And Efficacycarsgen Therapeutics Is Positioned To Make Significant Contributions To Cancer Treatment
